Cyclacel Pharmaceuticals Inc

+0.11 (+7.14%)
7:35:15 PM EDT: $1.65 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.59M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.03 Million
Adjusted EPS-$1.44
See more estimates
10-Day MA$1.61
50-Day MA$1.97
200-Day MA$3.43
See more pivots

Cyclacel Pharmaceuticals Inc Stock, NASDAQ:CYCC

200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey 07922
United States of America
Phone: +1.908.517.7330
Number of Employees:


Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.